Patent 10576047 was granted and assigned to Grünenthal GmbH on March, 2020 by the United States Patent and Trademark Office.
Formulations and methods are provided for the treatment of pain, and neuropathic pain in particular. The formulations are eutectic mixtures of a capsaicinoid and a local anesthetic agent and/or an anti-pruritic agent.